This is a type of lipid metabolism disorder that's caused by a genetic problem passed down from parents. It means your body's natural way of handling fats is faulty from birth.
Every report comes from a Lived member, sent anonymously.
Have you tried Crestor (Rosuvastatin) for Inherited Lipid Disorders?
Inherited lipid disorders are genetic conditions in which the body cannot properly break down, use or transport lipids, the fats and fat-like substances that include fatty acids, cholesterol and the fatty materials in cell membranes and nerve coverings. Usually an enzyme the body needs for this work is missing or does not work well. Depending on the disorder, fats either build up where they cause damage or cannot be turned into energy when the body needs them. This is an umbrella term rather than a single disease, and the disorders under it behave very differently. Lipid storage diseases, such as Gaucher disease, Fabry disease and Tay-Sachs disease, let fatty material accumulate inside cells, gradually harming the brain, nerves, liver, spleen, heart or bone marrow. Fatty acid oxidation disorders, such as medium-chain acyl-CoA dehydrogenase (MCAD) deficiency, stop the body from using fat as fuel, so trouble tends to appear suddenly during fasting or illness. Inherited cholesterol disorders, the most common being familial hypercholesterolemia, cause very high cholesterol in the blood from birth and raise the risk of early heart disease. Many of the storage and energy disorders are rare and some are severe, while others are mild or manageable, so what matters most is knowing the specific diagnosis.
These disorders are caused by changes (variants) in single genes passed down from parents. They are not caused by diet, stress or anything a parent did during pregnancy, although for some of them, fasting, illness or lifestyle can bring on or worsen problems. Most storage diseases and fatty acid oxidation disorders are recessive: a child is affected only when both parents carry one altered copy of the same gene. Carriers are usually healthy, and each child of two carriers has a 25% chance of having the disorder and a 50% chance of being a carrier. Fabry disease is passed on the X chromosome, so it typically affects males more severely, though women can also have symptoms. Familial hypercholesterolemia usually needs only one altered copy from one parent; a person who inherits two copies has a much more severe form that starts in childhood. Some disorders are more common in particular ancestries, for example Tay-Sachs and Gaucher disease in people of Ashkenazi Jewish descent. Carrier testing and genetic counseling can help families understand their risk before or during pregnancy.
Many babies are first identified through newborn screening, the heel-prick blood test done in the first days of life. Screening panels include several fatty acid oxidation disorders and, in some states, certain storage diseases such as Krabbe disease; exactly which disorders are tested varies by state. An abnormal screen is not a diagnosis; it means the baby needs prompt follow-up testing to confirm or rule out a disorder. Outside newborn screening, diagnosis starts with symptoms and family history. Because different disorders can look alike early on, a specialist (often a medical geneticist or metabolic doctor) uses targeted tests: enzyme activity measured in blood or other cells, blood or urine tests that look for stored or abnormal fatty substances, and genetic testing to identify the responsible gene variant. Imaging, eye exams, heart tests or occasionally a tissue biopsy can show how much the disorder has affected organs. For familial hypercholesterolemia, a very high low-density lipoprotein (LDL) cholesterol level (the main cholesterol carried in the blood that builds up in arteries), especially with early heart disease in relatives or cholesterol deposits in the skin or tendons, prompts genetic testing and testing of family members.
Treatment depends entirely on which disorder a person has, and it ranges from highly effective to purely supportive. For a few storage diseases, medicines can replace or work around the missing enzyme. Enzyme replacement therapy, given as regular intravenous infusions, is used for disorders such as Gaucher disease type 1 and Fabry disease, and in Fabry it can reduce fat buildup, ease pain and help preserve kidney and heart function in some people. Substrate reduction therapy, taken by mouth and used mainly for Gaucher disease type 1, lowers how much of the fatty substance the body makes. Krabbe disease and metachromatic leukodystrophy are storage diseases that damage the brain and nerves. Stem cell (bone marrow) transplant can improve survival in infants with Krabbe disease when done early, and a one-time gene therapy made from a person's own stem cells is approved for certain children with metachromatic leukodystrophy, ideally before symptoms begin. Some forms of Niemann-Pick disease now have approved medicines too: enzyme replacement for the effects of the type A and B form (acid sphingomyelinase deficiency) outside the brain, and oral medicines for the neurological effects of type C. These treatments generally cannot reverse brain damage already present, which is why early diagnosis matters. For many other storage diseases, including Tay-Sachs disease, care is supportive: nutrition, seizure control, physical therapy, help with breathing and swallowing, and treatment of complications. For fatty acid oxidation disorders, the core of treatment is preventing the body from needing to burn fat for energy. That means avoiding long gaps without food, eating regular meals and snacks, and, for long-chain disorders, a diet lower in long-chain fat with special medium-chain fat products prescribed by the metabolic team. Families receive a written sick-day plan or emergency letter that tells them and hospital staff what to do when the person is ill or cannot eat, since glucose given early can prevent a crisis. For familial hypercholesterolemia, a heart-healthy diet and cholesterol-lowering medicines, usually starting with a statin, substantially reduce the risk of heart attack and stroke. Many people need more than one medicine, such as ezetimibe (Zetia), a pill that lowers how much cholesterol the gut absorbs, or a PCSK9 inhibitor, an injected medicine that helps the liver clear more LDL from the blood. The severe two-copy form often needs apheresis, a procedure that filters LDL cholesterol out of the blood.
The outlook depends heavily on the specific disorder and the age at which it begins. Some infantile storage diseases progress quickly and shorten life to early childhood despite the best supportive care, while adult-onset forms of the same diseases may progress slowly over decades. Many people with Gaucher disease type 1, Fabry disease or familial hypercholesterolemia live full adult lives with ongoing treatment and monitoring, although how well treatment works varies, especially in classic Fabry disease. For fatty acid oxidation disorders, daily life centers on regular eating and planning ahead for illness, long sports sessions, surgery and, for women, pregnancy and delivery. With early diagnosis and a good plan, many children grow and develop normally, though some long-chain disorders also cause muscle breakdown with exercise or heart problems that need ongoing care. Most of these conditions mean lifelong care from a specialist team, which may include a metabolic doctor, dietitian, neurologist, cardiologist and genetic counselor. Regular checkups track organ function and adjust treatment. Because they are inherited, a diagnosis often leads to testing for siblings and other relatives, and to genetic counseling for future pregnancies. Clinical trials are active for several of these disorders, and patient organizations can connect families with experienced centers.
Ask for an evaluation if a child loses skills they had gained, develops unexplained weakness, an enlarged belly from a large liver or spleen, or burning pain in the hands and feet, or if relatives have a known inherited lipid disorder or heart attacks at a young age. A first seizure needs prompt medical assessment the same day. If a newborn screen comes back abnormal, arrange the follow-up testing promptly, as the screening program or pediatrician instructs. Meanwhile, keep the baby feeding regularly. If the baby becomes very sleepy, hard to wake or will not feed, take them to the emergency department right away and bring the screening result. For someone with a fatty acid oxidation disorder, contact the metabolic team promptly at the start of any illness that reduces eating, and follow the emergency letter. Vomiting or being unable to keep food down, unusual sleepiness or difficulty waking, seizures, or dark (tea- or cola-colored) urine with muscle pain are signs of a metabolic crisis that need emergency hospital care right away, with the emergency letter. For someone with familial hypercholesterolemia, chest pain or other signs of a heart attack, such as shortness of breath or pain spreading to the arm or jaw, are a reason to call 911 right away, even at a young age.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Inherited Lipid Disorders is like, what's helped you, or ask the community a question.